2016
DOI: 10.1016/j.ejmech.2016.04.076
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 27 publications
0
12
0
Order By: Relevance
“…33 Previously, our reports have shown that inverse agonists of ERRγ are able to restore the ability of radioiodine uptake in ATC cells by an increase of NIS protein that results from the downregulation of endogenous ERRγ protein and activation of MAP kinase. 31,30 Thus, we examined the effects of 6g and 10b on NIS, ERRγ, and phosphorylated ERK1/2 levels in ATC cells, CAL62 cells. 6g and 10b induced significant inhibition of endogenous ERRγ protein levels in CAL62 cells in a dose-dependent manner (Figure 2A,B and Figure 3A,B).…”
Section: Table 4 In Vitro Binding Selectivity Of the Screened 20 Comp...mentioning
confidence: 99%
See 2 more Smart Citations
“…33 Previously, our reports have shown that inverse agonists of ERRγ are able to restore the ability of radioiodine uptake in ATC cells by an increase of NIS protein that results from the downregulation of endogenous ERRγ protein and activation of MAP kinase. 31,30 Thus, we examined the effects of 6g and 10b on NIS, ERRγ, and phosphorylated ERK1/2 levels in ATC cells, CAL62 cells. 6g and 10b induced significant inhibition of endogenous ERRγ protein levels in CAL62 cells in a dose-dependent manner (Figure 2A,B and Figure 3A,B).…”
Section: Table 4 In Vitro Binding Selectivity Of the Screened 20 Comp...mentioning
confidence: 99%
“…28 On the basis of the structural motifs of 3, we have successfully demonstrated the synthesis of compound libraries that are more selective against ERRγ inverse agonists with improved absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles. 29,30 Moreover, we have broadened the therapeutic scope of these compounds based on our findings that 3 facilitates the responsiveness to radioiodine therapy by modulating sodium iodine symporter (NIS) function in anaplastic thyroid cancer (ATC) cells via ERRγ and MAP kinase signaling pathway. 31 On the basis of these encouraging results, we have validated the most promising compound of 3 analog from our previous studies for its ability to enhance NIS protein function, which is a key protein for radioiodine therapy, in ATC cells.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pam3CSK4 (TLR1/2 ligand; tri‐palmitoylated lipopeptide), poly(I:C) (TLR3 ligand), ultrapure LPS (TLR4 ligand) and R848 (TLR7/8 ligand) were purchased from Invivogen (San Diego, CA, USA); 614310 (TLR3/dsRNA complex inhibitor) was purchased from Merck Millipore (Billerica, MA, USA); and SP600125 (JNK inhibitor) and Bay11‐7082 (NF‐κB inhibitor) were purchased from Cell Signaling Technology (Danvers, MA, USA). GSK5182, an inverse agonist of ERRγ, was synthesized and dissolved for in vitro and in vivo experiments as previously described 29,34–36 . All reagents were dissolved in the recommended solvents.…”
Section: Methodsmentioning
confidence: 99%
“…GSK5182, an inverse agonist of ERR , was synthesized and dissolved for in vitro and in vivo experiments as previously described. 29,[34][35][36] All reagents were dissolved in the recommended solvents.…”
Section: Reagentsmentioning
confidence: 99%